<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04852029</url>
  </required_header>
  <id_info>
    <org_study_id>RMA-2021-01</org_study_id>
    <nct_id>NCT04852029</nct_id>
  </id_info>
  <brief_title>Prospective Assessment of Impact of Personalized Dosing of Low-dose Human Chorionic Gonadotropin (hCG) on in Vitro Fertilization (IVF) Outcomes</brief_title>
  <official_title>Prospective Assessment of Impact of Personalized Dosing of Low-dose Human Chorionic Gonadotropin (hCG) on in Vitro Fertilization (IVF) Outcomes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Reproductive Medicine Associates of New Jersey</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Reproductive Medicine Associates of New Jersey</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to determine the effect of tailoring dosage of low-dose hCG&#xD;
      secondary to serum hCG levels during IVF ovarian stimulation on sustained implantation rates&#xD;
      of preimplantation genetically tested euploid embryos.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objective of this study is to conduct a double-blind prospective randomized control trial&#xD;
      to determine if individualized hCG titration based on a patient's serum hCG level above or&#xD;
      below the predetermined serum hCG level improves IVF outcomes, primarily sustained&#xD;
      implantation rates. Patients who fall below the desired serum hCG threshold will be&#xD;
      randomized to either maintaining their current dose of low dose hCG or being increased.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">August 2021</start_date>
  <completion_date type="Anticipated">December 2023</completion_date>
  <primary_completion_date type="Anticipated">November 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>sustained implantation rate</measure>
    <time_frame>8 weeks gestational age</time_frame>
    <description>presence of fetal heart beat upon discharge</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">800</enrollment>
  <condition>Infertility, Female</condition>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>to remain on current dose of low dose hCG</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>increased dose of low dose hCG prescribed</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Low dose hCG</intervention_name>
    <description>Patients will either maintain the current dose of have an increased dose prescribed based on randomization</description>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_label>Intervention Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients whose physicians plan to prescribe low-dose hCG for ovarian stimulation&#xD;
&#xD;
          2. Age 18-46&#xD;
&#xD;
          3. Negative serum hCG prior to start of COH&#xD;
&#xD;
          4. BMI &gt;18 and &lt;35&#xD;
&#xD;
          5. Plan for ejaculated sperm use&#xD;
&#xD;
          6. Plan for PGT testing with euploid embryo transfer&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Administration of low-dose hCG during frozen embryo transfer cycle&#xD;
&#xD;
          2. Concomitant Menopur administration during ovarian stimulation or during frozen embryo&#xD;
             transfer cycle&#xD;
&#xD;
          3. BMI &lt;18 or &gt;35&#xD;
&#xD;
          4. Age &lt;18 or &gt;46&#xD;
&#xD;
          5. Presence of hydrosalpinxes that communicate with the endometrial cavity&#xD;
&#xD;
          6. Diagnosis of endometrial insufficiency: prior cycle with maximal endometrial thickness&#xD;
             â‰¤ 6mm, abnormal endometrial pattern (failure to attain a trilaminar appearance), and&#xD;
             persistent endometrial fluid&#xD;
&#xD;
          7. Uncorrected uterine factor infertility (uterine anomaly, submucosal myomas, uterine&#xD;
             septum)&#xD;
&#xD;
          8. Male partner with &lt;100,000 total motile spermatozoa per ejaculate (donor sperm is&#xD;
             acceptable)&#xD;
&#xD;
          9. Use of surgical procedures to obtain sperm&#xD;
&#xD;
         10. Couples undergoing IVF for fertility preservation with no immediate plan for&#xD;
             subsequent FET (embryo banking)&#xD;
&#xD;
         11. Personal history of repeated pregnancy loss (two or more unexplained clinical losses&#xD;
             defined by presence of fetal heartbeat)&#xD;
&#xD;
         12. Declination of PGT testing&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>46 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Christine Whitehead, BSN, RN</last_name>
    <phone>973-656-2841</phone>
    <email>clinicalresearchteam@ivirma.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Caroline Zuckerman, BS</last_name>
    <phone>973-656-2841</phone>
    <email>clinicalresearchteam@ivirma.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Reproductive Medicine Associates of New Jersey</name>
      <address>
        <city>Basking Ridge</city>
        <state>New Jersey</state>
        <zip>07920</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christine Whitehead, BSN, RN</last_name>
      <phone>973-656-2841</phone>
      <email>clinicalresearchteam@ivirma.com</email>
    </contact>
    <contact_backup>
      <last_name>Caroline Zuckerman, BS</last_name>
      <phone>973-656-2841</phone>
      <email>clinicalresearchteam@ivirma.com</email>
    </contact_backup>
    <investigator>
      <last_name>Richard T Scott, MD, HCLD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>April 15, 2021</study_first_submitted>
  <study_first_submitted_qc>April 20, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 21, 2021</study_first_posted>
  <last_update_submitted>August 10, 2021</last_update_submitted>
  <last_update_submitted_qc>August 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
    <mesh_term>Infertility, Female</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

